These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 164808)

  • 1. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
    Dutta SK; Shipley WD
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):445-8. PubMed ID: 164808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA; Mock RE; Lock TF
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
    Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Training of the immune system of foals against ERP virus infections by frequent vaccination with presently available commercial vaccines].
    Bürki F; Nowotny N; Rossmanith W; Pallan C; Möstl K
    Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):162-5. PubMed ID: 2540944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE; Love DN; Gilkerson JR; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):41-6. PubMed ID: 16513181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to equine herpesvirus 1 infection in foals during the first year of life.
    Kendrick JW; Stevenson W
    J Reprod Fertil Suppl; 1979; (27):615-8. PubMed ID: 225497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
    Cravens RL; Ellsworth MA; Sorensen CD; White AK
    J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell mediated immunity in equine herpesvirus type 1 infection I. In vitro lymphocyte blastogenesis and serum neutralization antibody in normal parturient and aborting mares.
    Dutta SK; Campbell DL
    Can J Comp Med; 1977 Oct; 41(4):404-8. PubMed ID: 200317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field study of the safety, immunogenicity, and efficacy of an inactivated equine rotavirus vaccine.
    Powell DG; Dwyer RM; Traub-Dargatz JL; Fulker RH; Whalen JW; Srinivasappa J; Acree WM; Chu HJ
    J Am Vet Med Assoc; 1997 Jul; 211(2):193-8. PubMed ID: 9227750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F; Nowotny N; Hofer A
    Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
    Johnson RP; Povey RC
    J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Equine rhinopneumonitis virus infection in horses. II (author's transl)].
    Dijkstra RG; de Boer GF
    Tijdschr Diergeneeskd; 1976 May; 101(9):494-7. PubMed ID: 178066
    [No Abstract]   [Full Text] [Related]  

  • 19. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT
    Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
    Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.